◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Novo Nordisk A/S (NVO) EBITDA 2006–TTM

Name: Novo Nordisk A/S (NVO) ebitda history 2006-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-19

Novo Nordisk A/S annual ebitda for fiscal 2025 was DKK 156.7 billion, an increase of 5.9% from DKK 147.9 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.

NVO Annual EBITDA

EBITDA (annual)	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
EBITDA	—	DKK 156.7B	DKK 147.9B	DKK 114.6B	DKK 76.8B	DKK 65.4B	DKK 59.3B	DKK 54.4B	DKK 51.6B	DKK 52.0B	DKK 51.1B	DKK 46.5B	DKK 37.6B	DKK 35.4B	DKK 30.6B	DKK 24.9B	DKK 21.3B	DKK 17.8B	DKK 14.9B	DKK 12.0B	DKK 11.3B

DKK; DKKM / DKKB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NVO Quarterly EBITDA

EBITDA (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
EBITDA	—	DKK 69.2B	DKK 39.7B	DKK 33.3B	DKK 43.6B	DKK 46.0B	DKK 45.8B	DKK 37.4B	DKK 35.7B

DKK; DKKM / DKKB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EBITDA at Comparable Companies

NVS EBITDA — Novartis AG ADR
AZN EBITDA — AstraZeneca PLC

More NVO metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow · Shares Outstanding

All NVO financial statements → Interactive NVO charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.